Armistice Capital »

Alto Neuroscience shares owned by Armistice Capital

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.6M 1.6M 4.02
2024-12-31 $2.7M 650k 4.23

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Alto Neuroscience

Falcon Edge Capital
Armistice Capital
Point72 Asset Management
Franklin Resources
Vanguard Group
Vestal Point Capital
Marshall Wace
72 Investment Holdings
Alkeon Capital Management
Northern Trust
Integral Health Asset Management
BlackRock
Millennium Management
Peapod Lane Capital
AWM Investment Company

View all funds holding Alto Neuroscience